Communities affected by TB everywhere have a right to benefit from scientific progress, including access to short-course, bedaquiline-based treatment regimens for drug-resistant TB.

Indian activists demand the introduction of the newer short-course TB preventive treatment regimens for people living with HIV.

A declaration of rights and demand for social and political solutions from people affected by TB at the 2018 Union World Conference on Lung Health.

Activists urge the Global Fund and donors to take prompt action to address the grave risks posed to countries that are rapidly shifting from pooled procurement of TB medicines and commodities.

Activists urge international donors and country governments to ensure access to quality health products as domestic financing policies push programs to the edge of procurement cliff.

In a symbolic display, activists invited conference participants to discard the injectable agents and commit to rapidly scaling up access to safer, more effective medicine.

Provocative distribution of yellow lemonade in urine collection cups calls attention to need for this simple, urine-based test.

Activists demand that Johnson & Johnson cut the price of bedaquiline in half, to no higher than $1 per day—$32 per person per month—double the price that researchers estimate bedaquiline could be sold for a profit.

Provocative distribution of yellow lemonade in urine collection cups calls attention to need for this simple, urine-based test.

Activists ask the company to drop the price of bedaquiline in all markets to $32 a month or lower.